SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast Activation Protein (FAP) targeted theranostics

  • Novartis has acquired global development and commercial rights to therapeutic applications for iTheranostics’ library […]
2021-05-19T01:02:30+00:00March 30th, 2021|News|

SOFIE Inc. enters into partnership with AUGMENTICON™

AUGMENTICON™, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools for a cost-effective, high-quality manufacturing […]

2021-05-19T01:09:10+00:00March 16th, 2021|News|

FAPI-74 PET/CT Using Either 18 F-AlF or Cold-Kit 68 Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients

Frederik L Giesel 1, Sebastian Adeberg

2021-04-26T00:57:10+00:00February 24th, 2021|Publications|

68 Ga-NOTA-FAPI-04 PET/CT in a patient with primary gastric diffuse large B cell lymphoma: comparisons with [ 18 F] FDG PET/CT

Guochang Wang # 1, Xiao Jin 

2021-04-26T01:20:52+00:00February 24th, 2021|Publications|

Fibroblast Activation Protein-Targeted PET/CT with 68 Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18 F-FDG PET/CT

Yaping Luo 1 2, Qingqing Pan

2021-04-26T00:28:11+00:00February 6th, 2021|Publications|

[ 18 F]FDG and [68 Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions

Bing Hao 1, Xiurong Wu 2, Yizhen […]

2021-04-26T01:14:17+00:00February 2nd, 2021|Publications|

Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer

Artineh Hayrapetian 1, Mark […]

2021-04-26T01:05:47+00:00February 1st, 2021|Publications|

Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18 F-Labeled FAP Inhibitor

Johannes Toms 1, Jürgen Kogler 1

2021-04-26T00:29:04+00:00December 6th, 2020|Publications|

SOFIE announces promotion of Mike Parisi to Vice President of Sales & Marketing

Mike brings nearly 25 years of Nuclear Medicine, Sales and Management experience to SOFIE. Mike […]

2021-05-19T01:04:30+00:00November 24th, 2020|News|

SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has signed a […]

2021-05-19T01:09:32+00:00November 13th, 2020|News|
© Copyright |   Privacy Policy   |   All Rights Reserved   |   Powered by jscTEK   1.703.787.7900           Email Us
Go to Top